Related Experiment Video
Updated: May 10, 2026
06:42
A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Investigational selective melatoninergic ligands for receptor subtype MT2
Ning Wan, Fang-Fang Zhang, Jia Ju
1Department of Pharmaceutics, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi, 710032, P.R. China.
Mini Reviews in Medicinal Chemistry
|July 3, 2013
Summary
Developing selective MT2 ligands is crucial for melatonin receptor research and drug discovery. This review details MT2-selective ligands, focusing on structural classes and structure-activity relationships to guide future drug development.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Neuroscience
Background:
- Melatonin receptor signaling influences diverse physiological processes via MT1, MT2, and MT3 subtypes.
- Current melatonin ligands lack subtype selectivity, hindering targeted therapeutic development.
- Developing subtype-selective ligands is essential for advancing melatonin receptor research and pharmacology.
Purpose of the Study:
- To review MT2-selective ligands developed in recent years.
- To provide guidance for the design of novel, highly selective MT2 ligands.
- To facilitate the exploration of potent and effective MT2-selective agents.
Main Methods:
- Comprehensive literature review of MT2-selective ligands.
- Analysis of binding data for MT1 and MT2 receptors.
- Classification of ligands based on structural characteristics.
Main Results:
- Detailed discussion of various structural classes of MT2-selective ligands.
- Exploration of pharmacophore models and receptor binding interactions.
- Analysis of structure-affinity and structure-selectivity relationships for MT2 ligands.
Conclusions:
- Understanding structure-activity relationships is key to designing selective MT2 ligands.
- This review offers insights into developing targeted pharmacological agents for MT2 receptors.
- Further exploration of MT2-selective ligands holds promise for novel therapeutic strategies.
More Related Videos
Related Concept Videos
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...